nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—brain cancer—bone cancer	0.444	0.531	CtDrD
Hydroxyurea—head and neck cancer—bone cancer	0.393	0.47	CtDrD
Hydroxyurea—RRM1—Nucleotide Metabolism—DHFR—bone cancer	0.00329	0.0725	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—DHFR—bone cancer	0.00297	0.0652	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide Metabolism—DHFR—bone cancer	0.00271	0.0597	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—NT5C3A—bone cancer	0.00262	0.0576	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—NT5C3A—bone cancer	0.00216	0.0474	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—DHFR—bone cancer	0.00212	0.0466	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—DHFR—bone cancer	0.00174	0.0384	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—DHFR—bone cancer	0.00174	0.0384	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—DHFR—bone cancer	0.00112	0.0247	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000975	0.0215	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—DHFR—bone cancer	0.000924	0.0203	CbGpPWpGaD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000875	0.0192	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000871	0.0192	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000803	0.0177	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—RB1—bone cancer	0.000797	0.0175	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—DHFR—bone cancer	0.000671	0.0148	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000625	0.0137	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—PLAU—bone cancer	0.000624	0.0137	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000565	0.0124	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000531	0.0117	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—PLAU—bone cancer	0.000514	0.0113	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RB1—bone cancer	0.000513	0.0113	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000512	0.0113	CbGpPWpGaD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000503	0.0111	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—ZW10—bone cancer	0.000487	0.0107	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000484	0.0106	CbGpPWpGaD
Hydroxyurea—Pain—Carboplatin—bone cancer	0.000483	0.0041	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—bone cancer	0.000473	0.0104	CbGpPWpGaD
Hydroxyurea—Blood uric acid increased—Cisplatin—bone cancer	0.000473	0.00401	CcSEcCtD
Hydroxyurea—Myelosuppression—Doxorubicin—bone cancer	0.00047	0.00399	CcSEcCtD
Hydroxyurea—Mucosal inflammation—Methotrexate—bone cancer	0.00046	0.00391	CcSEcCtD
Hydroxyurea—Body temperature increased—Carboplatin—bone cancer	0.000446	0.00379	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000446	0.0098	CbGpPWpGaD
Hydroxyurea—Skin exfoliation—Cisplatin—bone cancer	0.000443	0.00376	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000441	0.00969	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—ZW10—bone cancer	0.000435	0.00957	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000435	0.00956	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Epirubicin—bone cancer	0.000431	0.00366	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Methotrexate—bone cancer	0.000428	0.00364	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Methotrexate—bone cancer	0.000424	0.0036	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—RB1—bone cancer	0.000422	0.00929	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000422	0.00928	CbGpPWpGaD
Hydroxyurea—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.00042	0.00925	CbGpPWpGaD
Hydroxyurea—Eruption—Methotrexate—bone cancer	0.000414	0.00352	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000404	0.00889	CbGpPWpGaD
Hydroxyurea—Skin hyperpigmentation—Epirubicin—bone cancer	0.000401	0.0034	CcSEcCtD
Hydroxyurea—Mucosal inflammation—Doxorubicin—bone cancer	0.000398	0.00338	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Epirubicin—bone cancer	0.000396	0.00336	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—bone cancer	0.00039	0.00857	CbGpPWpGaD
Hydroxyurea—Eruption—Epirubicin—bone cancer	0.000388	0.00329	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.00038	0.00835	CbGpPWpGaD
Hydroxyurea—Bone marrow depression—Methotrexate—bone cancer	0.000377	0.0032	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Epirubicin—bone cancer	0.000375	0.00319	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000375	0.00825	CbGpPWpGaD
Hydroxyurea—Skin hyperpigmentation—Doxorubicin—bone cancer	0.000371	0.00315	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000369	0.00811	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000368	0.0081	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000367	0.00807	CbGpPWpGaD
Hydroxyurea—Febrile neutropenia—Doxorubicin—bone cancer	0.000367	0.00311	CcSEcCtD
Hydroxyurea—Renal failure acute—Cisplatin—bone cancer	0.000365	0.0031	CcSEcCtD
Hydroxyurea—Eruption—Doxorubicin—bone cancer	0.000359	0.00304	CcSEcCtD
Hydroxyurea—Bone marrow depression—Epirubicin—bone cancer	0.000353	0.003	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Doxorubicin—bone cancer	0.000347	0.00295	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RFC1—bone cancer	0.000334	0.00735	CbGpPWpGaD
Hydroxyurea—Blister—Epirubicin—bone cancer	0.000331	0.00281	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Methotrexate—bone cancer	0.00033	0.0028	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TUBB4B—bone cancer	0.00033	0.00725	CbGpPWpGaD
Hydroxyurea—Skin ulcer—Methotrexate—bone cancer	0.000327	0.00278	CcSEcCtD
Hydroxyurea—Bone marrow depression—Doxorubicin—bone cancer	0.000327	0.00277	CcSEcCtD
Hydroxyurea—Face oedema—Cisplatin—bone cancer	0.000325	0.00276	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Cisplatin—bone cancer	0.000316	0.00268	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000313	0.00688	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—RB1—bone cancer	0.000306	0.00674	CbGpPWpGaD
Hydroxyurea—Skin ulcer—Epirubicin—bone cancer	0.000306	0.0026	CcSEcCtD
Hydroxyurea—Blister—Doxorubicin—bone cancer	0.000306	0.0026	CcSEcCtD
Hydroxyurea—Breast disorder—Cisplatin—bone cancer	0.000305	0.00259	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RFC1—bone cancer	0.000299	0.00658	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000297	0.00653	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NDUFA12—bone cancer	0.000287	0.00632	CbGpPWpGaD
Hydroxyurea—Pancreatitis—Cisplatin—bone cancer	0.000286	0.00242	CcSEcCtD
Hydroxyurea—Skin ulcer—Doxorubicin—bone cancer	0.000283	0.00241	CcSEcCtD
Hydroxyurea—Pancytopenia—Cisplatin—bone cancer	0.000277	0.00235	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Methotrexate—bone cancer	0.000275	0.00233	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000273	0.00601	CbGpPWpGaD
Hydroxyurea—Amenorrhoea—Epirubicin—bone cancer	0.000271	0.0023	CcSEcCtD
Hydroxyurea—Hepatic enzyme increased—Methotrexate—bone cancer	0.000269	0.00229	CcSEcCtD
Hydroxyurea—Ulcer—Methotrexate—bone cancer	0.000269	0.00229	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Methotrexate—bone cancer	0.000259	0.0022	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RB1—bone cancer	0.000258	0.00568	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Epirubicin—bone cancer	0.000257	0.00218	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Cisplatin—bone cancer	0.000255	0.00216	CcSEcCtD
Hydroxyurea—Stomatitis—Cisplatin—bone cancer	0.000253	0.00215	CcSEcCtD
Hydroxyurea—Ulcer—Epirubicin—bone cancer	0.000252	0.00214	CcSEcCtD
Hydroxyurea—Amenorrhoea—Doxorubicin—bone cancer	0.000251	0.00213	CcSEcCtD
Hydroxyurea—Creatinine increased—Epirubicin—bone cancer	0.00025	0.00213	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Cisplatin—bone cancer	0.000246	0.00209	CcSEcCtD
Hydroxyurea—Skin exfoliation—Methotrexate—bone cancer	0.000243	0.00206	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Epirubicin—bone cancer	0.000243	0.00206	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NT5C3A—bone cancer	0.000238	0.00523	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Doxorubicin—bone cancer	0.000238	0.00202	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NDUFA12—bone cancer	0.000237	0.0052	CbGpPWpGaD
Hydroxyurea—Ulcer—Doxorubicin—bone cancer	0.000233	0.00198	CcSEcCtD
Hydroxyurea—Creatinine increased—Doxorubicin—bone cancer	0.000232	0.00197	CcSEcCtD
Hydroxyurea—Neoplasm—Methotrexate—bone cancer	0.00023	0.00196	CcSEcCtD
Hydroxyurea—Skin exfoliation—Epirubicin—bone cancer	0.000228	0.00193	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Methotrexate—bone cancer	0.000227	0.00193	CcSEcCtD
Hydroxyurea—Blood urea increased—Epirubicin—bone cancer	0.000225	0.00191	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Doxorubicin—bone cancer	0.000225	0.00191	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000218	0.00479	CbGpPWpGaD
Hydroxyurea—Rash maculo-papular—Epirubicin—bone cancer	0.000217	0.00184	CcSEcCtD
Hydroxyurea—Neoplasm—Epirubicin—bone cancer	0.000216	0.00183	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Epirubicin—bone cancer	0.000212	0.0018	CcSEcCtD
Hydroxyurea—Skin exfoliation—Doxorubicin—bone cancer	0.000211	0.00179	CcSEcCtD
Hydroxyurea—Blood urea increased—Doxorubicin—bone cancer	0.000208	0.00177	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—DHFR—bone cancer	0.000207	0.00456	CbGpPWpGaD
Hydroxyurea—Alopecia—Cisplatin—bone cancer	0.000206	0.00175	CcSEcCtD
Hydroxyurea—Hepatic failure—Methotrexate—bone cancer	0.000206	0.00175	CcSEcCtD
Hydroxyurea—Erythema—Cisplatin—bone cancer	0.000203	0.00172	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000203	0.00445	CbGpPWpGaD
Hydroxyurea—Rash maculo-papular—Doxorubicin—bone cancer	0.000201	0.0017	CcSEcCtD
Hydroxyurea—Renal failure acute—Methotrexate—bone cancer	0.0002	0.0017	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—bone cancer	0.000199	0.00169	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Doxorubicin—bone cancer	0.000196	0.00167	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NT5C3A—bone cancer	0.000196	0.00431	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000195	0.00429	CbGpPWpGaD
Hydroxyurea—Hepatic failure—Epirubicin—bone cancer	0.000193	0.00163	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Cisplatin—bone cancer	0.000188	0.0016	CcSEcCtD
Hydroxyurea—Anaemia—Cisplatin—bone cancer	0.000188	0.00159	CcSEcCtD
Hydroxyurea—Renal failure acute—Epirubicin—bone cancer	0.000187	0.00159	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—DHFR—bone cancer	0.000185	0.00408	CbGpPWpGaD
Hydroxyurea—Malaise—Cisplatin—bone cancer	0.000183	0.00155	CcSEcCtD
Hydroxyurea—Leukopenia—Cisplatin—bone cancer	0.000182	0.00154	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—bone cancer	0.000181	0.00154	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000179	0.00395	CbGpPWpGaD
Hydroxyurea—Hepatic failure—Doxorubicin—bone cancer	0.000178	0.00151	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000176	0.00387	CbGpPWpGaD
Hydroxyurea—Convulsion—Cisplatin—bone cancer	0.000176	0.00149	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000175	0.00384	CbGpPWpGaD
Hydroxyurea—Renal failure acute—Doxorubicin—bone cancer	0.000173	0.00147	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000172	0.00379	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000172	0.00146	CcSEcCtD
Hydroxyurea—Discomfort—Cisplatin—bone cancer	0.000171	0.00145	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—bone cancer	0.000168	0.00142	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—bone cancer	0.000167	0.00142	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—bone cancer	0.000167	0.00142	CcSEcCtD
Hydroxyurea—Oedema—Cisplatin—bone cancer	0.000166	0.00141	CcSEcCtD
Hydroxyurea—Infection—Cisplatin—bone cancer	0.000165	0.0014	CcSEcCtD
Hydroxyurea—Nervous system disorder—Cisplatin—bone cancer	0.000162	0.00138	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—bone cancer	0.000162	0.00138	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—bone cancer	0.000162	0.00138	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—bone cancer	0.000161	0.00137	CcSEcCtD
Hydroxyurea—Anorexia—Cisplatin—bone cancer	0.000158	0.00134	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—bone cancer	0.000157	0.00133	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—bone cancer	0.000156	0.00133	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CHEK2—bone cancer	0.000155	0.00341	CbGpPWpGaD
Hydroxyurea—Face oedema—Doxorubicin—bone cancer	0.000155	0.00131	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—bone cancer	0.000152	0.00129	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—bone cancer	0.00015	0.00127	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—bone cancer	0.000149	0.00127	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—bone cancer	0.000149	0.00127	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—bone cancer	0.000148	0.00125	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—bone cancer	0.000147	0.00124	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—bone cancer	0.000145	0.00123	CcSEcCtD
Hydroxyurea—Decreased appetite—Cisplatin—bone cancer	0.000144	0.00122	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—bone cancer	0.000143	0.00121	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—bone cancer	0.000143	0.00121	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—bone cancer	0.000143	0.00121	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—bone cancer	0.000143	0.00121	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—bone cancer	0.000142	0.00121	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—bone cancer	0.000142	0.0012	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000142	0.00311	CbGpPWpGaD
Hydroxyurea—Neutropenia—Epirubicin—bone cancer	0.00014	0.00119	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—bone cancer	0.00014	0.00119	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—bone cancer	0.000139	0.00118	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000138	0.00304	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Cisplatin—bone cancer	0.000137	0.00116	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—bone cancer	0.000136	0.00116	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—bone cancer	0.000136	0.00115	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—bone cancer	0.000135	0.00114	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—bone cancer	0.000133	0.00113	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—bone cancer	0.000133	0.00113	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—bone cancer	0.000133	0.00113	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—bone cancer	0.000131	0.00112	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BRCA2—bone cancer	0.000131	0.00289	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Cisplatin—bone cancer	0.000131	0.00111	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—bone cancer	0.000131	0.00111	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—bone cancer	0.00013	0.0011	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—bone cancer	0.000129	0.0011	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—bone cancer	0.000129	0.0011	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—bone cancer	0.000129	0.00109	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—bone cancer	0.000128	0.00109	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—bone cancer	0.000126	0.00107	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—bone cancer	0.000126	0.00107	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—bone cancer	0.000123	0.00105	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—bone cancer	0.000123	0.00105	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—bone cancer	0.000123	0.00105	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—bone cancer	0.000122	0.00104	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—bone cancer	0.000121	0.00103	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—bone cancer	0.00012	0.00102	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—bone cancer	0.00012	0.00102	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—bone cancer	0.00012	0.00102	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—bone cancer	0.000119	0.00101	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—bone cancer	0.000117	0.000991	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000116	0.00256	CbGpPWpGaD
Hydroxyurea—Angiopathy—Methotrexate—bone cancer	0.000116	0.000985	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—bone cancer	0.000115	0.000975	CcSEcCtD
Hydroxyurea—Diarrhoea—Cisplatin—bone cancer	0.000113	0.000962	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—bone cancer	0.000113	0.00096	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—bone cancer	0.000111	0.000945	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—bone cancer	0.000111	0.000945	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—bone cancer	0.000111	0.00094	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—bone cancer	0.000109	0.00239	CbGpPWpGaD
Hydroxyurea—Angiopathy—Epirubicin—bone cancer	0.000109	0.000922	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—bone cancer	0.000107	0.000912	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—bone cancer	0.000106	0.000898	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—bone cancer	0.000105	0.000894	CcSEcCtD
Hydroxyurea—Rash—Cisplatin—bone cancer	0.000104	0.000887	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—bone cancer	0.000104	0.000886	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ENO2—bone cancer	0.000104	0.00229	CbGpPWpGaD
Hydroxyurea—Erythema—Epirubicin—bone cancer	0.000104	0.000885	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—bone cancer	0.000103	0.000877	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—bone cancer	0.000103	0.000874	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—bone cancer	0.000101	0.000853	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—bone cancer	0.0001	0.000853	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—bone cancer	9.97e-05	0.000846	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—bone cancer	9.94e-05	0.000844	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—bone cancer	9.84e-05	0.000835	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—bone cancer	9.79e-05	0.000831	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDK4—bone cancer	9.74e-05	0.00214	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—bone cancer	9.67e-05	0.000821	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—DHFR—bone cancer	9.67e-05	0.00213	CbGpPWpGaD
Hydroxyurea—Convulsion—Methotrexate—bone cancer	9.65e-05	0.000819	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—bone cancer	9.64e-05	0.000819	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—bone cancer	9.63e-05	0.000818	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—bone cancer	9.47e-05	0.00208	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	9.42e-05	0.000799	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—bone cancer	9.4e-05	0.000798	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—bone cancer	9.37e-05	0.000795	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—bone cancer	9.33e-05	0.000792	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GNA11—bone cancer	9.04e-05	0.00199	CbGpPWpGaD
Hydroxyurea—Convulsion—Epirubicin—bone cancer	9.03e-05	0.000767	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—bone cancer	9.03e-05	0.000767	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—bone cancer	8.95e-05	0.00076	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—bone cancer	8.91e-05	0.000757	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—bone cancer	8.91e-05	0.000757	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—bone cancer	8.9e-05	0.000755	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—bone cancer	8.83e-05	0.000749	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	8.81e-05	0.000748	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—bone cancer	8.77e-05	0.000744	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—bone cancer	8.7e-05	0.000738	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—bone cancer	8.66e-05	0.000736	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—bone cancer	8.63e-05	0.000733	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ENO2—bone cancer	8.58e-05	0.00189	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—bone cancer	8.51e-05	0.000722	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—bone cancer	8.47e-05	0.00186	CbGpPWpGaD
Hydroxyurea—Infection—Epirubicin—bone cancer	8.45e-05	0.000717	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—bone cancer	8.36e-05	0.000709	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—bone cancer	8.34e-05	0.000708	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—bone cancer	8.33e-05	0.000707	CcSEcCtD
Hydroxyurea—Skin disorder—Epirubicin—bone cancer	8.26e-05	0.000701	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP3A4—bone cancer	8.19e-05	0.0018	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	8.15e-05	0.000692	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—bone cancer	8.11e-05	0.000689	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—bone cancer	8.11e-05	0.000688	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—bone cancer	8.1e-05	0.000688	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—bone cancer	8.08e-05	0.000686	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—bone cancer	8e-05	0.000679	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—DHFR—bone cancer	7.96e-05	0.00175	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—bone cancer	7.9e-05	0.000671	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—bone cancer	7.87e-05	0.000668	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—bone cancer	7.85e-05	0.000666	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—bone cancer	7.84e-05	0.000665	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—bone cancer	7.82e-05	0.000664	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—bone cancer	7.77e-05	0.00066	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—bone cancer	7.72e-05	0.000655	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—bone cancer	7.71e-05	0.000654	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—bone cancer	7.65e-05	0.000649	CcSEcCtD
Hydroxyurea—Dyspnoea—Epirubicin—bone cancer	7.58e-05	0.000644	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—bone cancer	7.56e-05	0.000642	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.52e-05	0.00165	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—bone cancer	7.5e-05	0.000637	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—bone cancer	7.49e-05	0.000636	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—bone cancer	7.49e-05	0.000636	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GNA11—bone cancer	7.44e-05	0.00164	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.41e-05	0.00163	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Epirubicin—bone cancer	7.39e-05	0.000628	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—bone cancer	7.34e-05	0.000623	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—bone cancer	7.33e-05	0.000623	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—bone cancer	7.27e-05	0.000618	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—bone cancer	7.27e-05	0.000618	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MDM2—bone cancer	7.22e-05	0.00159	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Methotrexate—bone cancer	7.19e-05	0.00061	CcSEcCtD
Hydroxyurea—Dyspnoea—Doxorubicin—bone cancer	7.02e-05	0.000596	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—bone cancer	7.01e-05	0.000595	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTP1—bone cancer	7.01e-05	0.00154	CbGpPWpGaD
Hydroxyurea—Somnolence—Doxorubicin—bone cancer	7e-05	0.000594	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—bone cancer	6.93e-05	0.000588	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—bone cancer	6.84e-05	0.000581	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—bone cancer	6.8e-05	0.000577	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—bone cancer	6.79e-05	0.000576	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP3A4—bone cancer	6.75e-05	0.00148	CbGpPWpGaD
Hydroxyurea—Pain—Doxorubicin—bone cancer	6.73e-05	0.000571	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—bone cancer	6.73e-05	0.000571	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—bone cancer	6.72e-05	0.000571	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—bone cancer	6.7e-05	0.000568	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—bone cancer	6.52e-05	0.000554	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—bone cancer	6.49e-05	0.000551	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.43e-05	0.00141	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.34e-05	0.00139	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—bone cancer	6.27e-05	0.000532	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—bone cancer	6.22e-05	0.000528	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—bone cancer	6.22e-05	0.000528	CcSEcCtD
Hydroxyurea—Asthenia—Epirubicin—bone cancer	6.1e-05	0.000518	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—bone cancer	6.01e-05	0.00051	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—bone cancer	5.82e-05	0.000494	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—bone cancer	5.8e-05	0.000492	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—bone cancer	5.78e-05	0.000491	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTP1—bone cancer	5.77e-05	0.00127	CbGpPWpGaD
Hydroxyurea—Rash—Methotrexate—bone cancer	5.73e-05	0.000487	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—bone cancer	5.73e-05	0.000486	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—bone cancer	5.69e-05	0.000483	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—bone cancer	5.65e-05	0.000479	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—bone cancer	5.63e-05	0.000478	CcSEcCtD
Hydroxyurea—Vomiting—Epirubicin—bone cancer	5.41e-05	0.000459	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—bone cancer	5.4e-05	0.000458	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—bone cancer	5.39e-05	0.000457	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—bone cancer	5.36e-05	0.000455	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—bone cancer	5.36e-05	0.000455	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—bone cancer	5.33e-05	0.000452	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—bone cancer	5.2e-05	0.000442	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—bone cancer	5.05e-05	0.000429	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—bone cancer	5e-05	0.000425	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—bone cancer	4.96e-05	0.000421	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—bone cancer	4.96e-05	0.000421	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—bone cancer	4.93e-05	0.000419	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—bone cancer	4.68e-05	0.000397	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—NDUFA12—bone cancer	4.51e-05	0.000991	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—bone cancer	4.14e-05	0.000911	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NT5C3A—bone cancer	3.73e-05	0.000821	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—bone cancer	3.63e-05	0.000798	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—bone cancer	2.99e-05	0.000658	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—bone cancer	1.64e-05	0.00036	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DHFR—bone cancer	1.52e-05	0.000334	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNA11—bone cancer	1.42e-05	0.000312	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000283	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—bone cancer	1.1e-05	0.000242	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—bone cancer	5.7e-06	0.000125	CbGpPWpGaD
